OKYO Pharma CEO to Present on Urcosimod at Bio International Convention
Ticker: OKYO · Form: 6-K · Filed: Jun 11, 2025 · CIK: 1849296
| Field | Detail |
|---|---|
| Company | Okyo Pharma LTD (OKYO) |
| Form Type | 6-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: presentation, biotech, clinical-development
TL;DR
OKYO Pharma CEO Gary Jacob presenting lead drug urcosimod at Bio International Convention on June 11, 2025.
AI Summary
On June 11, 2025, OKYO Pharma Ltd announced that its CEO, Gary S. Jacob, Ph.D., will present on the development of urcosimod at the Bio International Convention in Boston, MA. The presentation will focus on OKYO's lead clinical candidate.
Why It Matters
This presentation provides an opportunity for OKYO Pharma to showcase its lead drug candidate, urcosimod, to a key industry audience, potentially attracting investment and partnerships.
Risk Assessment
Risk Level: low — The filing is an announcement of a presentation and does not contain new financial information or significant operational changes.
Key Players & Entities
- OKYO Pharma Ltd (company) — Registrant
- Gary S. Jacob, Ph.D. (person) — CEO of OKYO Pharma Ltd
- urcosimod (drug) — OKYO's lead clinical candidate
- Bio International Convention (event) — Conference where presentation will be given
- Boston, MA (location) — Location of the convention
- June 11, 2025 (date) — Date of the announcement and presentation
FAQ
What is the specific topic of Dr. Jacob's presentation?
Dr. Jacob's presentation will cover the development of urcosimod, OKYO's lead clinical candidate.
When will the presentation take place?
The presentation will take place during the Bio International Convention in Boston, MA, on June 11, 2025.
Who is presenting on behalf of OKYO Pharma Ltd?
The CEO of OKYO Pharma Ltd, Gary S. Jacob, Ph.D., will be giving the oral presentation.
What is the name of OKYO Pharma's lead clinical candidate?
OKYO Pharma's lead clinical candidate is named urcosimod.
Where is the Bio International Convention being held?
The Bio International Convention is being held in Boston, MA.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 11, 2025 by Gary S. Jacob, Ph.D. regarding OKYO Pharma Ltd (OKYO).